Literature DB >> 22044541

Molecular characterization of the newly identified human parvovirus 4 in the family Parvoviridae.

Sai Lou1, Baoyan Xu, Qinfeng Huang, Ning Zhi, Fang Cheng, Susan Wong, Kevin Brown, Eric Delwart, Zhengwen Liu, Jianming Qiu.   

Abstract

Human parvovirus 4 (PARV4) is an emerging human virus, and little is known about the molecular aspects of PARV4 apart from its incomplete genome sequence, which lacks information of the termini. We analyzed the gene expression profile of PARV4 using a nearly full-length HPV4 genome in a replication competent system in 293 cells. We found that PARV4 utilizes two promoters to transcribe non-structural protein- and structural protein-encoding mRNAs, respectively, which were polyadenylated at the right end of the genome. Three major proteins, including the large non-structural protein NS1a, whose mRNA is spliced, and capsid proteins VP1 and VP2, were detected. Additional functional analysis of the NS1a revealed its capability to induce cell cycle arrest at G2/M phase in ex vivo-generated human hematopoietic stem cells. Taken together, our characterization of the molecular features of PARV4 suggests that PARV4 represents a new genus in the family Parvoviridae.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22044541      PMCID: PMC3229647          DOI: 10.1016/j.virol.2011.09.033

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  50 in total

1.  Nonsense mutations inhibit splicing of MVM RNA in cis when they interrupt the reading frame of either exon of the final spliced product.

Authors:  L K Naeger; R V Schoborg; Q Zhao; G E Tullis; D J Pintel
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

2.  Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly.

Authors:  S F Cotmore; A M D'abramo; C M Ticknor; P Tattersall
Journal:  Virology       Date:  1999-02-01       Impact factor: 3.616

3.  New DNA viruses identified in patients with acute viral infection syndrome.

Authors:  Morris S Jones; Amit Kapoor; Vladimir V Lukashov; Peter Simmonds; Frederick Hecht; Eric Delwart
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry.

Authors:  Glen A Farr; Li-guo Zhang; Peter Tattersall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-11       Impact factor: 11.205

5.  The interaction of heparin sulfate and adeno-associated virus 2.

Authors:  J Qiu; A Handa; M Kirby; K E Brown
Journal:  Virology       Date:  2000-03-30       Impact factor: 3.616

6.  Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild.

Authors:  Colin P Sharp; Matthew LeBreton; Kalle Kantola; Ahmadou Nana; Joseph Le Doux Diffo; Cyrille F Djoko; Ubald Tamoufe; John A Kiyang; Tafon G Babila; Eitel Mpoudi Ngole; Oliver G Pybus; Eric Delwart; Eric Delaporte; Martine Peeters; Maria Soderlund-Venermo; Klaus Hedman; Nathan D Wolfe; Peter Simmonds
Journal:  J Virol       Date:  2010-07-28       Impact factor: 5.103

Review 7.  Parvoviral host range and cell entry mechanisms.

Authors:  Susan F Cotmore; Peter Tattersall
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

8.  The abundant R2 mRNA generated by aleutian mink disease parvovirus is tricistronic, encoding NS2, VP1, and VP2.

Authors:  Jianming Qiu; Fang Cheng; David Pintel
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

9.  High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.

Authors:  Ruth Simmons; Colin Sharp; Stuart Sims; Henrik Kloverpris; Philip Goulder; Peter Simmonds; Paul Bowness; Paul Klenerman
Journal:  J Infect Dis       Date:  2011-05-15       Impact factor: 5.226

10.  Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα.

Authors:  Aaron Yun Chen; Steve Kleiboeker; Jianming Qiu
Journal:  PLoS Pathog       Date:  2011-06-16       Impact factor: 6.823

View more
  7 in total

1.  Human parvovirus B19: a mechanistic overview of infection and DNA replication.

Authors:  Yong Luo; Jianming Qiu
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

Review 2.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M.

Authors:  Sai Lou; Yong Luo; Fang Cheng; Qinfeng Huang; Weiran Shen; Steve Kleiboeker; John F Tisdale; Zhengwen Liu; Jianming Qiu
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

4.  Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection.

Authors:  Mao-Yuan Chen; Chien-Ching Hung; Kuang-Lun Lee
Journal:  Virol J       Date:  2015-06-19       Impact factor: 4.099

Review 5.  PARV4: an emerging tetraparvovirus.

Authors:  Philippa C Matthews; Amna Malik; Ruth Simmons; Colin Sharp; Peter Simmonds; Paul Klenerman
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

6.  Persistent viremia by a novel parvovirus in a slow loris (Nycticebus coucang) with diffuse histiocytic sarcoma.

Authors:  Marta Canuti; Cathy V Williams; Sashi R Gadi; Maarten F Jebbink; Bas B Oude Munnink; Seyed Mohammad Jazaeri Farsani; John M Cullen; Lia van der Hoek
Journal:  Front Microbiol       Date:  2014-12-01       Impact factor: 5.640

7.  Complete genome sequences of two isolates of human parvovirus 4 from patients with acute encephalitis syndrome.

Authors:  Shantanu Prakash; Amita Jain; Akanksha Seth; Arvind K Singh; Bhawana Jain
Journal:  Genome Announc       Date:  2015-01-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.